The Lancet Respiratory Medicine

The Lancet Respiratory Medicine delivers comprehensive, clinically-focused coverage on all areas of respiratory medicine and critical care, including but not limited to: COPD, asthma, cystic fibrosis, IPF, pneumonia, influenza, tuberculosis, sarcoidosis, pulmonary hypertension, sleep medicine, respiratory infections, pulmonary vascular disease, lung cancer, tobacco control, thoracic and reconstructive surgery, mesothelioma, and palliative medicine. Continuing in The Lancet's tradition of publishing high-impact content that influences medical practice, each monthly issue of The Lancet Respiratory Medicine contains Original Research, Reviews, Personal Views, Comments, and News.

The Lancet Respiratory Medicine is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within 8 weeks of submission (on average) and published Online First on www.thelancet.com before appearing in print.

Editor in Chief: Emma Grainger
2024
The Lancet Respiratory Medicine
Global Print Circulation
10,000
Avg. Global Monthly Visits
191,277
Avg. Global Monthly Unique Visitors
105,893
Avg. Global Monthly Page Views
134,896
Avg. Global eTOC Distribution
73,827
Circulation updated on 1st July, 2023, based on 12-month monthly average July 2022-June 2023 eTOC Metrics: 12 Month Average of eTOC sends - July 2022 to June 2023 Monthly average web metrics based on the period of July 2022 to June 2023

Contacts

Display Advertising

Recruitment Advertising

Have a question or need assistance?

Contact us now and a Sales Representative will be in touch.